Targeting and eliminating paediatric cancers with chimeric antigen receptor engineered natural killer cells, a new hope for cancer immunotherapy (2021–2023)

Grant type:
Children's Hospital Foundation Immunotherapy Research Grants
Researchers:
Funded by:
The Children's Hospital Foundation